TXG logo

10x Genomics, Inc. (TXG) Free cash flow

annual FCF:

-$6.73M+$57.99M(+89.60%)
December 31, 2024

Summary

  • As of today (August 16, 2025), TXG annual free cash flow is -$6.73 million, with the most recent change of +$57.99 million (+89.60%) on December 31, 2024.
  • During the last 3 years, TXG annual FCF has risen by +$115.92 million (+94.51%).
  • TXG annual FCF is now at all-time high.

Performance

TXG Free cash flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTXGcash flow metrics

quarterly FCF:

$16.13M-$16.33M(-50.31%)
June 30, 2025

Summary

  • As of today (August 16, 2025), TXG quarterly free cash flow is $16.13 million, with the most recent change of -$16.33 million (-50.31%) on June 30, 2025.
  • Over the past year, TXG quarterly FCF has increased by +$12.51 million (+345.83%).
  • TXG quarterly FCF is now -50.31% below its all-time high of $32.46 million, reached on March 31, 2025.

Performance

TXG quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTXGcash flow metrics

TTM FCF:

$56.88M+$12.51M(+28.20%)
June 30, 2025

Summary

  • As of today (August 16, 2025), TXG TTM free cash flow is $56.88 million, with the most recent change of +$12.51 million (+28.20%) on June 30, 2025.
  • Over the past year, TXG TTM FCF has increased by +$90.33 million (+270.04%).
  • TXG TTM FCF is now at all-time high.

Performance

TXG TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTXGcash flow metrics

Free cash flow Formula

FCF = Cash From Operations − CAPEX

TXG Free cash flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+89.6%+345.8%+270.0%
3 y3 years+94.5%+136.5%+135.2%
5 y5 years+17.3%+144.5%+223.8%

TXG Free cash flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+95.9%-50.3%+135.0%at high+134.4%
5 y5-yearat high+97.4%-50.3%+110.6%at high+119.7%
alltimeall timeat high+97.4%-50.3%+110.6%at high+119.7%

TXG Free cash flow History

DateAnnualQuarterlyTTM
Jun 2025
-
$16.13M(-50.3%)
$56.88M(+28.2%)
Mar 2025
-
$32.46M(-443.0%)
$44.36M(-759.3%)
Dec 2024
-$6.73M(-89.6%)
-$9.46M(-153.3%)
-$6.73M(-126.9%)
Sep 2024
-
$17.75M(+390.7%)
$25.04M(-174.9%)
Jun 2024
-
$3.62M(-119.4%)
-$33.45M(-54.8%)
Mar 2024
-
-$18.64M(-183.5%)
-$73.95M(+14.3%)
Dec 2023
-$64.72M(-60.8%)
$22.31M(-154.8%)
-$64.72M(-42.7%)
Sep 2023
-
-$40.74M(+10.5%)
-$113.04M(-4.6%)
Jun 2023
-
-$36.88M(+292.1%)
-$118.44M(-5.8%)
Mar 2023
-
-$9.41M(-63.8%)
-$125.74M(-23.9%)
Dec 2022
-$165.27M(+34.7%)
-$26.01M(-43.6%)
-$165.27M(+2.6%)
Sep 2022
-
-$46.14M(+4.4%)
-$161.07M(-0.2%)
Jun 2022
-
-$44.18M(-9.7%)
-$161.38M(+25.4%)
Mar 2022
-
-$48.94M(+124.4%)
-$128.64M(+4.9%)
DateAnnualQuarterlyTTM
Dec 2021
-$122.65M(-52.1%)
-$21.81M(-53.0%)
-$122.65M(-51.6%)
Sep 2021
-
-$46.44M(+305.7%)
-$253.28M(-4.0%)
Jun 2021
-
-$11.45M(-73.3%)
-$263.77M(-8.6%)
Mar 2021
-
-$42.95M(-71.8%)
-$288.58M(+12.6%)
Dec 2020
-$256.29M(+3048.6%)
-$152.44M(+167.7%)
-$256.29M(+147.1%)
Sep 2020
-
-$56.94M(+57.0%)
-$103.73M(+125.8%)
Jun 2020
-
-$36.26M(+240.3%)
-$45.95M(+145.1%)
Mar 2020
-
-$10.65M(-9053.8%)
-$18.75M(+130.3%)
Dec 2019
-$8.14M(-90.2%)
$119.00K(-86.0%)
-$8.14M(-1.4%)
Sep 2019
-
$848.00K(-109.4%)
-$8.26M(-9.3%)
Jun 2019
-
-$9.06M(>+9900.0%)
-$9.11M(>+9900.0%)
Mar 2019
-
-$49.00K
-$49.00K
Dec 2018
-$83.12M(+475.0%)
-
-
Dec 2017
-$14.46M
-
-

FAQ

  • What is 10x Genomics, Inc. annual free cash flow?
  • What is the all time high annual FCF for 10x Genomics, Inc.?
  • What is 10x Genomics, Inc. annual FCF year-on-year change?
  • What is 10x Genomics, Inc. quarterly free cash flow?
  • What is the all time high quarterly FCF for 10x Genomics, Inc.?
  • What is 10x Genomics, Inc. quarterly FCF year-on-year change?
  • What is 10x Genomics, Inc. TTM free cash flow?
  • What is the all time high TTM FCF for 10x Genomics, Inc.?
  • What is 10x Genomics, Inc. TTM FCF year-on-year change?

What is 10x Genomics, Inc. annual free cash flow?

The current annual FCF of TXG is -$6.73M

What is the all time high annual FCF for 10x Genomics, Inc.?

10x Genomics, Inc. all-time high annual free cash flow is -$6.73M

What is 10x Genomics, Inc. annual FCF year-on-year change?

Over the past year, TXG annual free cash flow has changed by +$57.99M (+89.60%)

What is 10x Genomics, Inc. quarterly free cash flow?

The current quarterly FCF of TXG is $16.13M

What is the all time high quarterly FCF for 10x Genomics, Inc.?

10x Genomics, Inc. all-time high quarterly free cash flow is $32.46M

What is 10x Genomics, Inc. quarterly FCF year-on-year change?

Over the past year, TXG quarterly free cash flow has changed by +$12.51M (+345.83%)

What is 10x Genomics, Inc. TTM free cash flow?

The current TTM FCF of TXG is $56.88M

What is the all time high TTM FCF for 10x Genomics, Inc.?

10x Genomics, Inc. all-time high TTM free cash flow is $56.88M

What is 10x Genomics, Inc. TTM FCF year-on-year change?

Over the past year, TXG TTM free cash flow has changed by +$90.33M (+270.04%)
On this page